SAN DIEGO, Oct. 15, 2024 (GLOBE NEWSWIRE) — Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2024 financial and operating results after the market closes on Thursday, November 7, 2024, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.
To participate in the conference call by telephone, dial (888) 596-4144 or (646) 968-2525 and reference Maravai LifeSciences, Conference ID 9502421. The call will also be available via live or archived webcast on the “Investors” section of the Maravai web site at https://investors.maravai.com.
About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world’s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.
CONTACT: Contact Information: Deb Hart Maravai LifeSciences + 1 858-988-5917 ir@maravai.com
According to Pixalate's research, 'My FitnessPal' ranked at the top on both Google Play Store…
According to Pixalate's research, ‘Gangstar Vegas: World of Crime’ on Google Play Store generated an…
According to Pixalate's research, ‘Pro Des Mots’ led on Apple App Store in France, ‘SimCity’…
IBTA Robbins LLP is Investigating Allegations that Ibotta, Inc. (IBTA) Misled Investors in Connection with…
Santa Clara, April 21, 2025 (GLOBE NEWSWIRE) -- Santa Clara, California - The global Edge…
According to Pixalate's research, the app ‘My Fitness Pal’ in Canada generated an estimated $230K…
This website uses cookies.